Earnings calendar/VYGR
Voyager Therapeutics, Inc. (VYGR)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 9, 2026
Expected from filing cadence
EPS target
$-0.41
Estimates not sourced
Revenue target
$6.3M
Estimates not sourced
Trailing EPS (avg 4Q)
$-0.45
Beat rate last 4: 100%
Latest EPS YoY
+29.8%
vs 2025-08-06
Latest revenue YoY
-39.1%
How results look so far
Trailing revenue (avg 4Q)
$8.6M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS beat
EPS actual / est
$-0.40 / $-0.48
+17.3%
Revenue actual / est
$3.2M / $4.5M
-30.0%
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/9/2026upcoming | $-0.41 | Pending | — | $6.3M | Pending | — |
| 8/6/2026 | $-0.48 | $-0.40 | +17.3% | $4.5M | $3.2M | -30.0% |
| 5/11/2026upcoming | $-0.54 | Pending | — | $8.8M | Pending | — |
| 5/7/2026 | $-0.54 | $-0.47 | +13.0% | $8.8M | $2.6M | -70.5% |
| 5/5/2026upcoming | $-0.54 | Pending | — | $8.2M | Pending | — |
| 3/10/2026upcoming | $-0.54 | Pending | — | $10.5M | Pending | — |
| 3/9/2026 | $-0.54 | $-0.46 | +14.8% | $10.5M | $15.3M | +46.2% |
| 11/10/2025 | $-0.53 | $-0.47 | +11.3% | $10.5M | $13.4M | +27.4% |
| 8/6/2025 | $-0.48 | $-0.57 | -18.7% | $7.9M | $5.2M | -33.8% |
| 5/6/2025 | $-0.35 | $-0.53 | -51.4% | $13.9M | $6.5M | -53.5% |
| 3/11/2025 | $-0.35 | $-0.59 | -68.6% | $12.9M | $6.3M | -51.5% |
| 11/12/2024 | $-0.45 | $-0.16 | +64.4% | $15.5M | $24.6M | +59.4% |
| 8/6/2024 | $-0.38 | $-0.18 | +52.6% | $9.5M | $29.6M | +212.7% |
| 5/13/2024 | $-0.44 | $-0.20 | +54.5% | $9.4M | $19.5M | +107.4% |
| 2/28/2024 | $-0.29 | $1.25 | +531.0% | $20.6M | $90.1M | +336.6% |
| 11/6/2023 | $-0.58 | $-0.59 | -1.7% | $5.6M | $4.6M | -17.0% |
| 8/3/2023 | $-0.59 | $-0.51 | +13.6% | $1.8M | $4.9M | +174.2% |
| 5/9/2023 | $0.77 | $2.94 | +281.8% | $61.1M | $150.5M | +146.2% |
| 3/7/2023 | $-0.57 | $-0.61 | -7.0% | $4.2M | $41.1M | +880.6% |
| 11/8/2022 | $-0.32 | $0.45 | +240.6% | $9.4M | $41.1M | +336.3% |
Need VYGR data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.